About Selfapy

The digital health company Selfapy closed a financing round of 7 million euros. In addition to the new strategic investor Medice Arzneimittel, all existing investors are also involved. Berlin, 17.02.2023 – The Berlin-based company Selfapy, which offers effective digital therapeutics for people with mental illnesses, has gained a strong partner in Medice Arzneimittel as an investor. The funding round was supported by the investment bank Bryan, Garnier & Co.. On December 23, 2022,

The first apps available via prescription have made it into reimbursement; the next ones are awaiting approval. Is digital medicine about to make a breakthrough in Germany? 15 months after the start of the Digital Healthcare Act, start-ups, health insurance companies, authorities and investors take stock of the situation: What are still the biggest challenges? Which business models can digital therapies offer in the long term? The current issue of the MedTech Radar publication takes a look b

Selfapy is Germany’s leading provider of online therapy for mental stress and already cooperates with 16 health insurance companiesSHS expects strong impetus from the new Digital Supply Act (DVG) for digital health companies Fifth investment of the fifth SHS fund: The Tübingen-based medical technology and life science investor SHS Gesellschaft für Beteiligungsmanagement has taken a stake in the Berlin-based digital health company Selfapy GmbH as part of a capital increase. In addi